Advertisement

Oral mucosal mouthwash with chlorhexidine does not reduce the incidence of ventilator-associated pneumonia in critically ill children: A randomised controlled trial

Published:August 07, 2021DOI:https://doi.org/10.1016/j.aucc.2021.06.011

      Abstract

      Background

      Ventilator-associated pneumonia (VAP) is one of the most frequently encountered causes of hospital-acquired infection and results in high morbidity among intubated patients. Few trials have investigated the efficacy of oral care with chlorhexidine (CHX) mouthwash for the prevention of VAP in the paediatric population.

      Objectives

      The objective of this study was to assess the efficacy of CHX mouthwash in the prevention of VAP and to determine risk factors for VAP in children aged 1 month to 18 years admitted to the paediatric intensive care unit (PICU).

      Methods

      This was a prospective, randomised, controlled, double-blind trial performed in the PICU. Patients were randomised into two groups receiving CHX (0.12%) (n = 88) or placebo (0.9% NaCl) (n = 86) and were followed up for VAP development. The main outcome measures were incidence of VAP, duration of hospital stay, duration of PICU stay, duration of ventilation, mortality, and the characteristics of organisms isolated in cases with VAP.

      Results:

      No difference was observed in the incidence of VAP and the type and distribution of organisms in the two groups (p > 0.05). In the CHX and placebo groups, we identified 21 and 22 patients with VAP, respectively. Incidence per 1000 ventilation days was 29.5 events in the CHX group and 35.1 events in the placebo group. Gram-negative bacteria were most common (71.4% in CHX vs. 54.5% in placebo). The use of 0.12% CHX did not influence hospital stay, PICU stay, ventilation, and mortality (p > 0.05). Multivariate analysis identified duration of ventilation as the only independent risk factor for VAP (p = 0.001).

      Conclusion

      The use of 0.12% CHX did not reduce VAP frequency among critically ill children. The only factor that increased VAP frequency was longer duration on ventilation. It appears that low concentration of CHX is not effective for VAP prevention, especially in the presence of multiresistant bacteria.

      ClinicalTrials.gov Identifier

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Australian Critical Care
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Safdar N.
        • Crnich C.J.
        • Maki D.G.
        The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention.
        Respir Care. 2005; 50 (discussion 39-41): 725-739
        • Patria M.F.
        • Chidini G.
        • Ughi L.
        • Montani C.
        • Prandi E.
        • Galeone C.
        • et al.
        Ventilator-associated pneumonia in an Italian pediatric intensive care unit: a prospective study.
        World J Pediatr. 2013; 9: 365-368
        • O'horo J.C.
        • Thompson D.
        • Safdar N.
        Is the gram stain useful in the microbiologic diagnosis of VAP? A meta-analysis.
        Clin Infect Dis. 2012; 55: 551-561
        • Joram N.
        • De Saint Blanquat L.
        • Stamm D.
        • Launay E.
        • Gras-Le Guen C.
        Healthcare-associated infection prevention in pediatric intensive care units: a review.
        Eur J Clin Microbiol Infect Dis. 2012; 31: 2481-2490
        • Kalanuria A.A.
        • Ziai W.
        • Mirski M.
        Ventilator-associated pneumonia in the ICU.
        Crit Care. 2014; 18: 208
        • Venkatachalam V.
        • Hendley J.O.
        • Willson D.F.
        The diagnostic dilemma of ventilator-associated pneumonia in critically ill children.
        Pediatr Crit Care Med. 2011; 12: 286-296
        • Bigham M.T.
        • Amato R.
        • Bondurrant P.
        • Fridriksson J.
        • Krawczeski C.D.
        • Raake J.
        • et al.
        Ventilator-associated pneumonia in the pediatric intensive care unit: characterizing the problem and implementing a sustainable solution.
        J Pediatr. 2009; 154 (582-587.e2)
        • Huskins W.C.
        Quality improvement interventions to prevent healthcare-associated infections in neonates and children.
        Curr Opin Pediatr. 2012; 24: 103-112
        • Liu B.
        • Li S.Q.
        • Zhang S.M.
        • Xu P.
        • Zhang X.
        • Zhang Y.H.
        • et al.
        Risk factors of ventilator-associated pneumonia in pediatric intensive care unit: a systematic review and meta-analysis.
        J Thorac Dis. 2013; 5: 525-531
        • Whittaker C.J.
        • Klier C.M.
        • Kolenbrander P.E.
        Mechanisms of adhesion by oral bacteria.
        Annu Rev Microbiol. 1996; 50: 513-552
        • Zolfaghari P.S.
        • Wyncoll D.L.
        The tracheal tube: gateway to ventilator-associated pneumonia.
        Crit Care. 2011; 15: 310
        • Tablan O.C.
        • Anderson L.J.
        • Besser R.
        • Bridges C.
        • Hajjeh R.
        Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the healthcare infection control practices advisory committee.
        MMWR Recomm Rep. 2004; 53: 1-36
        • Koff M.D.
        • Corwin H.L.
        • Beach M.L.
        • Surgenor S.D.
        • Loftus R.W.
        Reduction in ventilator associated pneumonia in a mixed intensive care unit after initiation of a novel hand hygiene program.
        J Crit Care. 2011; 26: 489-495
        • Coffin S.E.
        • Klompas M.
        • Classen D.
        • Arias K.M.
        • Podgorny K.
        • Anderson D.J.
        • et al.
        Strategies to prevent ventilator-associated pneumonia in acute care hospitals.
        Infect Control Hosp Epidemiol. 2008; 29: S31-S40
      1. Improvement IFH. How-to-Guide: prevent a ventilator associated pneumonia [Available from: http://www.ihi.org/IHI/Topics/.

        • De Neef M.
        • Bakker L.
        • Dijkstra S.
        • Raymakers-Janssen P.
        • Vileito A.
        • Ista E.
        Effectiveness of a ventilator care bundle to prevent ventilator-associated pneumonia at the PICU: a systematic review and meta-analysis.
        Pediatr Crit Care Med. 2019; 20: 474-480
        • Klompas M.
        • Li L.
        • Kleinman K.
        • Szumita P.M.
        • Massaro A.F.
        Associations between ventilator bundle components and outcomes.
        JAMA Intern Med. 2016; 176: 1277-1283
        • Sinuff T.
        • Muscedere J.
        • Cook D.J.
        • Dodek P.M.
        • Anderson W.
        • Keenan S.P.
        • et al.
        Implementation of clinical practice guidelines for ventilator-associated pneumonia: a multicenter prospective study.
        Crit Care Med. 2013; 41: 15-23
        • Zhang T.T.
        • Tang S.S.
        • Fu L.J.
        The effectiveness of different concentrations of chlorhexidine for prevention of ventilator-associated pneumonia: a meta-analysis.
        J Clin Nurs. 2014; 23: 1461-1475
        • Labeau S.O.
        • Van De Vyver K.
        • Brusselaers N.
        • Vogelaers D.
        • Blot S.I.
        Prevention of ventilator-associated pneumonia with oral antiseptics: a systematic review and meta-analysis.
        Lancet Infect Dis. 2011; 11: 845-854
        • Meinberg M.C.
        • Cheade Mde F.
        • Miranda A.L.
        • Fachini M.M.
        • Lobo S.M.
        The use of 2% chlorhexidine gel and toothbrushing for oral hygiene of patients receiving mechanical ventilation: effects on ventilator-associated pneumonia.
        Rev Bras Ter Intensiva. 2012; 24: 369-374
        • Li J.
        • Xie D.
        • Li A.
        • Yue J.
        Oral topical decontamination for preventing ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials.
        J Hosp Infect. 2013; 84: 283-293
        • Shi Z.
        • Xie H.
        • Wang P.
        • Zhang Q.
        • Wu Y.
        • Chen E.
        • et al.
        Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia.
        Cochrane Database Syst Rev. 2013; 8Cd008367
        • Klompas M.
        • Speck K.
        • Howell M.D.
        • Greene L.R.
        • Berenholtz S.M.
        Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis.
        JAMA Intern Med. 2014; 174: 751-761
        • Osman S.
        • Al Talhi Y.M.
        • Aldabbagh M.
        • Baksh M.
        • Osman M.
        • Azzam M.
        The incidence of ventilator-associated pneumonia (VAP) in a tertiary-care center: comparison between pre- and post-VAP prevention bundle.
        J Infect Publ Health. 2020; 13: 552-557
        • Kusahara D.M.
        • Peterlini M.A.
        • Pedreira M.L.
        Oral care with 0.12% chlorhexidine for the prevention of ventilator-associated pneumonia in critically ill children: randomised, controlled and double blind trial.
        Int J Nurs Stud. 2012; 49: 1354-1363
        • Jácomo A.D.
        • Carmona F.
        • Matsuno A.K.
        • Manso P.H.
        • Carlotti A.P.
        Effect of oral hygiene with 0.12% chlorhexidine gluconate on the incidence of nosocomial pneumonia in children undergoing cardiac surgery.
        Infect Control Hosp Epidemiol. 2011; 32: 591-596
        • Sebastian M.R.
        • Lodha R.
        • Kapil A.
        • Kabra S.K.
        Oral mucosal decontamination with chlorhexidine for the prevention of ventilator-associated pneumonia in children - a randomized, controlled trial.
        Pediatr Crit Care Med. 2012; 13: e305-e310
        • Schulz K.F.
        • Altman D.G.
        • Moher D.
        CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.
        J Pharmacol Pharmacother. 2010; 1: 100-107
        • Dat V.Q.
        • Geskus R.B.
        • Wolbers M.
        • Loan H.T.
        • Yen L.M.
        • Binh N.T.
        • et al.
        Continuous versus intermittent endotracheal cuff pressure control for the prevention of ventilator-associated respiratory infections in Vietnam: study protocol for a randomised controlled trial.
        Trials. 2018; 19: 217
        • Rath S.K.
        • Singh M.
        Comparative clinical and microbiological efficacy of mouthwashes containing 0.2% and 0.12% chlorhexidine.
        Dent Res J (Isfahan). 2013; 10: 364-369
        • Ames N.J.
        • Sulima P.
        • Yates J.M.
        • Mccullagh L.
        • Gollins S.L.
        • Soeken K.
        • et al.
        Effects of systematic oral care in critically ill patients: a multicenter study.
        Am J Crit Care. 2011; 20: e103-e114
        • Garner J.S.
        • Jarvis W.R.
        • Emori T.G.
        • Horan T.C.
        • Hughes J.M.
        CDC definitions for nosocomial infections, 1988.
        Am J Infect Contr. 1988; 16: 128-140
        • Wall R.J.
        • Ely E.W.
        • Talbot T.R.
        • Weinger M.B.
        • Williams M.V.
        • Reischel J.
        • et al.
        Evidence-based algorithms for diagnosing and treating ventilator-associated pneumonia.
        J Hosp Med. 2008; 3: 409-422
        • Foglia E.
        • Meier M.D.
        • Elward A.
        Ventilator-associated pneumonia in neonatal and pediatric intensive care unit patients.
        Clin Microbiol Rev. 2007; 20 (table of contents): 409-425
        • Langley J.M.
        • Bradley J.S.
        Defining pneumonia in critically ill infants and children.
        Pediatr Crit Care Med. 2005; 6: S9-s13
        • Aa K.
        • Dm E.-L.
        • F W.
        Ventilator associated pneumonia in a neonatal intensive care unit. vol. 9. 2013: 251-258 (11)
        • Pollack M.M.
        • Patel K.M.
        • Ruttimann U.E.
        PRISM III: an updated pediatric risk of mortality score.
        Crit Care Med. 1996; 24: 743-752
        • Fourrier F.
        • Dubois D.
        • Pronnier P.
        • Herbecq P.
        • Leroy O.
        • Desmettre T.
        • et al.
        Effect of gingival and dental plaque antiseptic decontamination on nosocomial infections acquired in the intensive care unit: a double-blind placebo-controlled multicenter study.
        Crit Care Med. 2005; 33: 1728-1735
        • Panchabhai T.S.
        • Dangayach N.S.
        • Krishnan A.
        • Kothari V.M.
        • Karnad D.R.
        Oropharyngeal cleansing with 0.2% chlorhexidine for prevention of nosocomial pneumonia in critically ill patients: an open-label randomized trial with 0.01% potassium permanganate as control.
        Chest. 2009; 135: 1150-1156
        • Johnstone L.
        • Spence D.
        • Koziol-Mcclain J.
        Oral hygiene care in the pediatric intensive care unit: practice recommendations.
        Pediatr Nurs. 2010; 36 (quiz 7): 85-96
        • Segers P.
        • Speekenbrink R.G.
        • Ubbink D.T.
        • Van Ogtrop M.L.
        • De Mol B.A.
        Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial.
        J Am Med Assoc. 2006; 296: 2460-2466
        • De Cristofano A.
        • Peuchot V.
        • Canepari A.
        • Franco V.
        • Perez A.
        • Eulmesekian P.
        Implementation of a ventilator-associated pneumonia prevention bundle in a single PICU.
        Pediatr Crit Care Med. 2016; 17: 451-456
        • Grap M.J.
        • Munro C.L.
        • Elswick Jr., R.K.
        • Sessler C.N.
        • Ward K.R.
        Duration of action of a single, early oral application of chlorhexidine on oral microbial flora in mechanically ventilated patients: a pilot study.
        Heart Lung. 2004; 33: 83-91
        • Cieplik F.
        • Jakubovics N.S.
        • Buchalla W.
        • Maisch T.
        • Hellwig E.
        • Al-Ahmad A.
        Resistance toward chlorhexidine in oral bacteria - is there cause for concern?.
        Front Microbiol. 2019; 10: 587
        • Bonten M.J.
        • Kollef M.H.
        • Hall J.B.
        Risk factors for ventilator-associated pneumonia: from epidemiology to patient management.
        Clin Infect Dis. 2004; 38: 1141-1149
        • Samransamruajkit R.
        • Jirapaiboonsuk S.
        • Siritantiwat S.
        • Tungsrijitdee O.
        • Deerojanawong J.
        • Sritippayawan S.
        • et al.
        Effect of frequency of ventilator circuit changes (3 vs 7 days) on the rate of ventilator-associated pneumonia in PICU.
        J Crit Care. 2010; 25: 56-61
        • Elward A.M.
        • Warren D.K.
        • Fraser V.J.
        Ventilator-associated pneumonia in pediatric intensive care unit patients: risk factors and outcomes.
        Pediatrics. 2002; 109: 758-764
        • Chastre J.
        • Fagon J.Y.
        Ventilator-associated pneumonia.
        Am J Respir Crit Care Med. 2002; 165: 867-903
        • Blot S.
        Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units.
        Clin Microbiol Infect. 2008; 14: 5-13
        • Parreco J.
        • Soe-Lin H.
        • Byerly S.
        • Lu N.
        • Ruiz G.
        • Yeh D.D.
        • et al.
        Multi-Center outcomes of chlorhexidine oral decontamination in intensive care units.
        Surg Infect (Larchmt). 2020; 21: 659-664
        • Price R.
        • Maclennan G.
        • Glen J.
        Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis.
        BMJ. 2014; 348g2197
        • Deschepper M.
        • Waegeman W.
        • Eeckloo K.
        • Vogelaers D.
        • Blot S.
        Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study.
        Intensive Care Med. 2018; 44: 1017-1026
        • Blot S.
        Antiseptic mouthwash, the nitrate-nitrite-nitric oxide pathway, and hospital mortality: a hypothesis generating review.
        Intensive Care Med. 2021; 47: 28-38
        • Lizy C.
        • Swinnen W.
        • Labeau S.
        • Poelaert J.
        • Vogelaers D.
        • Vandewoude K.
        • et al.
        Cuff pressure of endotracheal tubes after changes in body position in critically ill patients treated with mechanical ventilation.
        Am J Crit Care. 2014; 23: e1-e8